Amedisys, UnitedHealth Group

Amedisys Stock Gains as Merger Extension Raises Hope for UnitedHealth Deal
Amedisys stock climbed Friday after the provider of home health care agreed to waive its right to terminate a merger agreement with UnitedHealth Group, bolstering expectations that the deal will succeed despite a government attempt to block it.
Amedisys and UnitedHealth Extend Merger Deadline - What's Going On?
Amedisys Inc (NASDAQ:AMED) shares are trading higher on Friday after the company announced it extended its merger deadline with UnitedHealth Group Incorporated (NYSE:UNH). In an exchange filing, the companies entered into a waiver agreement,
UnitedHealth, Amedisys Move Ahead With New Waiver To Complete $3.3 Billion Deal
UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) have extended the deadline to finalize their merger agreement until 2025, as stated in a filing
Amedisys, UnitedHealth Group Extend Deadline To Complete $3.3B Merger
Key Takeaways UnitedHealth Group and Amedisys agreed to extend the deadline to complete their $3.3 billion merger. The deal had been expected to be completed this week, but federal and state regulators moved to block it,
Merger Drama: UnitedHealth-Amedisys Waive Termination Rights, Face DOJ Hurdles with Extended Deal
Declared Friday UnitedHealth Group ( NYSE:UNH) and Amedisys ( NASDAQ:AMED) have waived off their rights to terminate theirmerger agreement, extending the timeframe for the $3.3 billion purchase into late 2025. The decision was revealed in a regulatory disclosure.
Optum, Amedisys extend merger deadline amid legal challenge
Optum and home health provider Amedisys have extended the deadline for their proposed $3.3 billion merger amid a legal challenge from the Department of Justice. Here are 10 things to know: 1. In a Dec. 26 regulatory filing, the companies agreed to waive their right to terminate the deal if it fails to close before a specified deadline.
UnitedHealth, Amedisys extend merger deadline amid DOJ scrutiny
Investing.com -- UnitedHealth (NYSE: UNH) and Amedisys (NASDAQ: AMED) have decided to extend the deadline for their $3.3 billion merger agreement into the next year, according to a recent filing. This decision comes as the deal is under close examination by the U.S. Department of Justice.
UnitedHealth Group waives deadlines to complete $3.3B home health acquisition
UnitedHealth Group has filed for more time to complete a $3.3 billion deal to buy Amedisys, a home health care and hospice company, after the companies agreed to waive deadlines in the face of antitrust scrutiny.
bovnews1d
Amedisys (AMED) Stock Rallies as Merger Drama Unfolds: Here’s What You Need to Know
Amedisys is a prominent player in the home healthcare industry. Specializing in home health care and hospice services, the company provides essential services to patients in the comfort of their homes ...
5 Things to Know Before the Stock Market Opens
Stock futures are lower in pre-market trading while Treasury yields rise and Apple shares edge higher as the iPhone maker's ...
Amedisys, Rigetti Computing And Other Big Stocks Moving Higher On Friday
Amedisys-UnitedHealth announced in filing earlier, they extended merger deadline until Dec. 31, 2025. Amedisys shares gained ...
Mergers that were blocked or challenged by the Biden admin in 2024
Several prominent mergers and acquisitions have been blocked or challenged by the Biden-Harris administration in 2024, ...
Top Stock Movers Now: Lamb Weston, Amedisys, Supermicro, and More
Lamb Weston shares gained following reports activist investor Jana Partners took another step in its effort to force changes ...